Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo Scarpa

Showing results (311-320 of 602) with videos related to

Pageof 61
Sort By:
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Critical Reviews in Oncology/Hematology|December 15, 2015
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaNicola Silvestris, Vito Longo, Francesco Cellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayEdoardo Missiaglia, Irene Dalai, Stefano Barbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Specialized DNA arrays for the differentiation of pancreatic tumorsMalte Buchholz, Hans A Kestler, Andrea Bauer, et al.
Endocrine-Related Cancer|June 23, 2010
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of casesVincenzo Corbo, Irene Dalai, Maria Scardoni, et al.
Journal for Immunotherapy of Cancer|September 4, 2021
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancerCarmine Carbone, Geny Piro, Antonio Agostini, et al.
Annals of Epidemiology|January 13, 2006
Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretionPierluigi Cocco, Patrick S Moore, Maria G Ennas, et al.
Scientific Reports|June 9, 2017
Splice variants as novel targets in pancreatic ductal adenocarcinomaJun Wang, Laurent Dumartin, Andrea Mafficini, et al.
Oncoimmunology|September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinomaGeny Piro, Francesca Simionato, Carmine Carbone, et al.
International Journal of Legal Medicine|January 21, 2025
iForensic, multicentric validation of digital whole slide images (WSI) in forensic histopathology setting according to the College of American Pathologists guidelinesNicola Pigaiani, Antonio Oliva, Vito Cirielli, et al.
Pageof 61

Showing results (311-320 of 602) with videos related to

Sort By:
Pageof 61
Annals of Surgery|June 21, 2016
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNMGiovanni Marchegiani, Stefano Andrianello, Giuseppe Malleo, et al.
Critical Reviews in Oncology/Hematology|December 15, 2015
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinomaNicola Silvestris, Vito Longo, Francesco Cellini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathwayEdoardo Missiaglia, Irene Dalai, Stefano Barbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Specialized DNA arrays for the differentiation of pancreatic tumorsMalte Buchholz, Hans A Kestler, Andrea Bauer, et al.
Endocrine-Related Cancer|June 23, 2010
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of casesVincenzo Corbo, Irene Dalai, Maria Scardoni, et al.
Journal for Immunotherapy of Cancer|September 4, 2021
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancerCarmine Carbone, Geny Piro, Antonio Agostini, et al.
Annals of Epidemiology|January 13, 2006
Effect of urban traffic, individual habits, and genetic polymorphisms on background urinary 1-hydroxypyrene excretionPierluigi Cocco, Patrick S Moore, Maria G Ennas, et al.
Scientific Reports|June 9, 2017
Splice variants as novel targets in pancreatic ductal adenocarcinomaJun Wang, Laurent Dumartin, Andrea Mafficini, et al.
Oncoimmunology|September 22, 2017
A circulating T<sub>H</sub>2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinomaGeny Piro, Francesca Simionato, Carmine Carbone, et al.
International Journal of Legal Medicine|January 21, 2025
iForensic, multicentric validation of digital whole slide images (WSI) in forensic histopathology setting according to the College of American Pathologists guidelinesNicola Pigaiani, Antonio Oliva, Vito Cirielli, et al.
Pageof 61